The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis

Affiliations

• ¹ Department of Rheumatology, Broomfield Hospital, Chelmsford, Essex, Department of Rheumatology, Queen Alexandra Hospital, Portsmouth, Department of Rheumatology, Addenbrookes Hospital, Cambridge, National Rheumatoid Arthritis Society, Maidenhead, Berkshire, Academic Section of Musculoskeletal Disease, University of Leeds, Leeds, Department of Medicine, Cardiff University School of Medicine, Cardiff, Department of Rheumatology, Kings College London, London, Musculoskeletal Research Group, Newcastle University, Newcastle, Department of Rheumatology, Inverclyde Royal Hospital, Glasgow, Department of Rheumatology, Royal Victoria Hospital, Belfast and Department of Rheumatology, Addenbrookes Hospital, Cambridge, UK. a.malaviya@nhs.net.
• ² Department of Rheumatology, Broomfield Hospital, Chelmsford, Essex, Department of Rheumatology, Queen Alexandra Hospital, Portsmouth, Department of Rheumatology, Addenbrookes Hospital, Cambridge, National Rheumatoid Arthritis Society, Maidenhead, Berkshire, Academic Section of Musculoskeletal Disease, University of Leeds, Leeds, Department of Medicine, Cardiff University School of Medicine, Cardiff, Department of Rheumatology, Kings College London, London, Musculoskeletal Research Group, Newcastle University, Newcastle, Department of Rheumatology, Inverclyde Royal Hospital, Glasgow, Department of Rheumatology, Royal Victoria Hospital, Belfast and Department of Rheumatology, Addenbrookes Hospital, Cambridge, UK.